Intersect ENT (XENT) Reports Slight Revenue Miss; Piper Jaffray Cuts Price Target to $23
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/12/2026
- Wall Street ends higher as SpaceX's market debut dominates
- SpaceX prices historic IPO at $135/share in largest ever new listing
- 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
- UBS cuts gold price forecasts on delayed Fed easing outlook
- Brent falls to lowest since March on expected peace deal
- NASDAQ adds five companies to NASDAQ-100 index in quarterly rebalance
- Adobe CFO Dan Durn to depart company in June 2026
- Oppenheimer Starts SpaceX (SPCX) at Outperform, PT $190, 'space infrastructure appears structurally advantaged'
- Pentagon reportedly locked down, hazmat teams responding
- Super Micro Computer establishes $1.25 billion stock sale agreement
Pre-Open Stock Movers 11/05: (AWAY) (SD) (FB) Higher; (XENT) (LCI) (BLUE) Lower (more...)
November 5, 2015 9:32 AM ESTION Geophysical (NYSE: IO) 30.8% HIGHER; reported Q3 EPS of ($0.10), $0.11 better than the analyst estimate of ($0.21). Revenue for the quarter came in at $53.5 million versus the consensus estimate of $36.47 million. ION Geophysical announced that its board of directors has authorized the Company to repurchase, from time to time from November 10, 2015 through November 10, 2017, up to $25 million in shares of its outstanding common stock.
Intersect ENT (NASDAQ: XENT) 23.4% LOWER; reported Q3 EPS of ($0.35), $0.06... More
After-Hours Movers 11/04: (IO) (AWAY) (FB) Higher; (XENT) (FEYE) (WFM) Lower (more...)
November 4, 2015 6:09 PM ESTION Geophysical (NYSE: IO) 30.8% HIGHER; reported Q3 EPS of ($0.10), $0.11 better than the analyst estimate of ($0.21). Revenue for the quarter came in at $53.5 million versus the consensus estimate of $36.47 million. ION Geophysical announced that its board of directors has authorized the Company to repurchase, from time to time from November 10, 2015 through November 10, 2017, up to $25 million in shares of its outstanding common stock.
Intersect ENT (NASDAQ: XENT) 23.4% LOWER; reported Q3 EPS of ($0.35), $0.06 worse than the analyst estimate of ($0.29). Revenue for the... More
Intersect ENT (XENT) Misses Q3 EPS by 6c
November 4, 2015 5:43 PM ESTIntersect ENT (NASDAQ: XENT) reported Q3 EPS of ($0.35), $0.06 worse than the analyst estimate of ($0.29). Revenue for the quarter came in at $14.2 million versus the consensus estimate of $14.8 million.
For earnings history and earnings-related data on Intersect ENT (XENT) click here.
... MoreTrading Radar 11/4: Facebook (FB), Qualcomm (QCOM), MetLife (MET), Time Warner (TWX), Michael Kors (KORS) Report
November 3, 2015 2:45 PM ESTThe Trading Radar highlights key earnings and economic announcements for the next trading session:
Before Markets Open:
Economics:
7:00am EDT
8:15am EDT
ADP Employment Change - Street sees 180k8:30am EDT
Trade Balance - Street sees ($43.0B)Earnings:
02micro (Nasdaq: OIIM) - consensus loss $0.08
3D Systems (NYSE: DDD) - consensus EPS $0.08
Abraxas Petroleum (Nasdaq: AXAS) - consensus loss... More

